英国NextGen Sciences  
Nextgen Sciences公司总部位于英国的剑桥郡，分部设在美国的波士顿，该公司主要为蛋白质研究提供整体解决方案。其产品为全自动、大型蛋白质组学研究设备，包括三类设备：蛋白表达系统、自动双向电泳系统、蛋白芯片工作站。该公司现与德国Protagen AG 公司（1999年成立，专注于蛋白质组学研究实验技术。）建立合作伙伴关系。增强了其在蛋白质表达领域的实力。

NextGen Group PLC (LSE:NGG) is a provider of protein biomarker services, biomarkerexpress™, for pharmaceutical and biotech companies globally.

NextGen's range of services, which include biomarker discovery, assay development and a testing laboratory, are employed by customers as a key part of the drug and diagnostic development process. NextGen uses advanced and proprietary techniques to develop accurate, precise and robust biomarker assays, which are used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalised treatment for patients.

As well as biomarker services, NextGen also has a range of capabilities on offer to clients, including protein identification, characterization, quantitation and proteome mapping, and has an enviable record for providing high-quality fast results.

NextGen's management team has a track record of progressing technology solutions and delivering first-class services to market, and the company has worked with 16 of the top 20 pharmaceutical companies and has several Master Service Agreements in place.

NextGen continues to invest in cutting-edge technologies and form strategic alliances to offer the best quality and most comprehensive protein biomarker services to its pharmaceutical and biotech customers.